Skip to main content

Table 1 Characteristics of the SSc cohort (n = 44)

From: Nailfold videocapillaroscopy and serum VEGF levels in scleroderma are associated with internal organ involvement

  SSc (n = 44)
F (%) vs M (%) 42 (95.4 %) vs 2 (4.6 %)
Median age, yy(range) 66 (34–80)
Median disease duration, yy (range) 9 (1–16)
D (%) vs L (%) 10 (22.7 %) vs 34 (77.3 %)
anti-Scl70 (+) (%) 12 (27.3 %)
ACA (+) (%) 22 (50 %)
Others Abs (%)a 10 (22.7 %)
Iloprost (%) 25 (56.8 %)
Bosentan (%) 7 (15.9 %)
Ulcers (%) 15 (34.1 %)
Early NVC pattern (%) 6 (13.6 %)
Active NVC pattern (%) 20 (45.4 %)
Late NVC pattern (%) 18 (40.9 %)
GE disease (%) 36 (81.8 %)
sPAP >45 mmHg (%) 3 (6.8 %)
DLCO <50 % (%)
DLCO/AV <50 % (%)
7 (15.9 %)
1 (2.3 %)
FVC <80 % (%) 8 (18.2 %)
Honeycombing lung (%) 4 (9.1 %)
Rodnan skin score >14 (%) 9 (20.4 %)
  1. ACA anti-centromere, anti-Scl70 anti-topoisomerase, AV alveolar volume, D diffuse, DLCO carbon monoxide diffusing capacity, F female, FVC forced vital capacity, GE gastro-esophageal, L limited, M male, NVC nailfold videocapillaroscopy, sPAP systolic pulmonary artery pressure on echocardiography, SSc systemic sclerosis, vs versus
  2. a1/10 anti-Ku, 2/10 anti-RNApol III, 1/10 anti-Th/To
\